Cargando…

Auditory Dysfunction Among Individuals With Neurofibromatosis Type 1

IMPORTANCE: Neurofibromatosis type 1 (NF1) affects hearing through disruption of central auditory processing. The mechanisms, functional severity, and management implications are unclear. OBJECTIVE: To investigate auditory neural dysfunction and its perceptual consequences in individuals with NF1. D...

Descripción completa

Detalles Bibliográficos
Autores principales: Rance, Gary, Zanin, Julien, Maier, Alice, Chisari, Donella, Haebich, Kristina M., North, Kathryn N., Dabscheck, Gabriel, Seal, Marc L., Delatycki, Martin B., Payne, Jonathan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649832/
https://www.ncbi.nlm.nih.gov/pubmed/34870681
http://dx.doi.org/10.1001/jamanetworkopen.2021.36842
_version_ 1784611082222960640
author Rance, Gary
Zanin, Julien
Maier, Alice
Chisari, Donella
Haebich, Kristina M.
North, Kathryn N.
Dabscheck, Gabriel
Seal, Marc L.
Delatycki, Martin B.
Payne, Jonathan M.
author_facet Rance, Gary
Zanin, Julien
Maier, Alice
Chisari, Donella
Haebich, Kristina M.
North, Kathryn N.
Dabscheck, Gabriel
Seal, Marc L.
Delatycki, Martin B.
Payne, Jonathan M.
author_sort Rance, Gary
collection PubMed
description IMPORTANCE: Neurofibromatosis type 1 (NF1) affects hearing through disruption of central auditory processing. The mechanisms, functional severity, and management implications are unclear. OBJECTIVE: To investigate auditory neural dysfunction and its perceptual consequences in individuals with NF1. DESIGN, SETTING, AND PARTICIPANTS: This case-control study included children and adults with NF1 and control participants matched on age, sex, and hearing level. Patients were recruited through specialist neurofibromatosis and neurogenetic outpatient clinics between April and September 2019. An evaluation of auditory neural activity, monaural/binaural processing, and functional hearing was conducted. Diffusion-weighted magnetic resonance imaging (MRI) data were collected from a subset of participants (10 children with NF1 and 10 matched control participants) and evaluated using a fixel-based analysis of apparent fiber density. MAIN OUTCOMES AND MEASURES: Type and severity of auditory dysfunction evaluated via laboratory testing and questionnaire data. RESULTS: A total of 44 participants (18 [41%] female individuals) with NF1 with a mean (SD) age of 16.9 (10.7) years and 44 control participants (18 [41%] female individuals) with a mean (SD) age of 17.2 (10.2) years were included in the study. Overall, 11 participants (25%) with NF1 presented with evidence of auditory neural dysfunction, including absent, delayed, or low amplitude electrophysiological responses from the auditory nerve and/or brainstem, compared with 1 participant (2%) in the control group (odds ratio [OR], 13.03; 95% CI, 1.59-106.95). Furthermore, 14 participants (32%) with NF1 showed clinically abnormal speech perception in background noise compared with 1 participant (2%) in the control group (OR, 20.07; 95% CI, 2.50-160.89). Analysis of diffusion-weighted MRI data of participants with NF1 showed significantly lower apparent fiber density within the ascending auditory brainstem pathways. The regions identified corresponded to the neural dysfunction measured using electrophysiological assessment. CONCLUSIONS AND RELEVANCE: The findings of this case-control study could represent new neurobiological and clinical features of NF1. Auditory dysfunction severe enough to impede developmental progress in children and restrict communication in older participants is a common neurobiological feature of the disorder.
format Online
Article
Text
id pubmed-8649832
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-86498322021-12-08 Auditory Dysfunction Among Individuals With Neurofibromatosis Type 1 Rance, Gary Zanin, Julien Maier, Alice Chisari, Donella Haebich, Kristina M. North, Kathryn N. Dabscheck, Gabriel Seal, Marc L. Delatycki, Martin B. Payne, Jonathan M. JAMA Netw Open Original Investigation IMPORTANCE: Neurofibromatosis type 1 (NF1) affects hearing through disruption of central auditory processing. The mechanisms, functional severity, and management implications are unclear. OBJECTIVE: To investigate auditory neural dysfunction and its perceptual consequences in individuals with NF1. DESIGN, SETTING, AND PARTICIPANTS: This case-control study included children and adults with NF1 and control participants matched on age, sex, and hearing level. Patients were recruited through specialist neurofibromatosis and neurogenetic outpatient clinics between April and September 2019. An evaluation of auditory neural activity, monaural/binaural processing, and functional hearing was conducted. Diffusion-weighted magnetic resonance imaging (MRI) data were collected from a subset of participants (10 children with NF1 and 10 matched control participants) and evaluated using a fixel-based analysis of apparent fiber density. MAIN OUTCOMES AND MEASURES: Type and severity of auditory dysfunction evaluated via laboratory testing and questionnaire data. RESULTS: A total of 44 participants (18 [41%] female individuals) with NF1 with a mean (SD) age of 16.9 (10.7) years and 44 control participants (18 [41%] female individuals) with a mean (SD) age of 17.2 (10.2) years were included in the study. Overall, 11 participants (25%) with NF1 presented with evidence of auditory neural dysfunction, including absent, delayed, or low amplitude electrophysiological responses from the auditory nerve and/or brainstem, compared with 1 participant (2%) in the control group (odds ratio [OR], 13.03; 95% CI, 1.59-106.95). Furthermore, 14 participants (32%) with NF1 showed clinically abnormal speech perception in background noise compared with 1 participant (2%) in the control group (OR, 20.07; 95% CI, 2.50-160.89). Analysis of diffusion-weighted MRI data of participants with NF1 showed significantly lower apparent fiber density within the ascending auditory brainstem pathways. The regions identified corresponded to the neural dysfunction measured using electrophysiological assessment. CONCLUSIONS AND RELEVANCE: The findings of this case-control study could represent new neurobiological and clinical features of NF1. Auditory dysfunction severe enough to impede developmental progress in children and restrict communication in older participants is a common neurobiological feature of the disorder. American Medical Association 2021-12-06 /pmc/articles/PMC8649832/ /pubmed/34870681 http://dx.doi.org/10.1001/jamanetworkopen.2021.36842 Text en Copyright 2021 Rance G et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Rance, Gary
Zanin, Julien
Maier, Alice
Chisari, Donella
Haebich, Kristina M.
North, Kathryn N.
Dabscheck, Gabriel
Seal, Marc L.
Delatycki, Martin B.
Payne, Jonathan M.
Auditory Dysfunction Among Individuals With Neurofibromatosis Type 1
title Auditory Dysfunction Among Individuals With Neurofibromatosis Type 1
title_full Auditory Dysfunction Among Individuals With Neurofibromatosis Type 1
title_fullStr Auditory Dysfunction Among Individuals With Neurofibromatosis Type 1
title_full_unstemmed Auditory Dysfunction Among Individuals With Neurofibromatosis Type 1
title_short Auditory Dysfunction Among Individuals With Neurofibromatosis Type 1
title_sort auditory dysfunction among individuals with neurofibromatosis type 1
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649832/
https://www.ncbi.nlm.nih.gov/pubmed/34870681
http://dx.doi.org/10.1001/jamanetworkopen.2021.36842
work_keys_str_mv AT rancegary auditorydysfunctionamongindividualswithneurofibromatosistype1
AT zaninjulien auditorydysfunctionamongindividualswithneurofibromatosistype1
AT maieralice auditorydysfunctionamongindividualswithneurofibromatosistype1
AT chisaridonella auditorydysfunctionamongindividualswithneurofibromatosistype1
AT haebichkristinam auditorydysfunctionamongindividualswithneurofibromatosistype1
AT northkathrynn auditorydysfunctionamongindividualswithneurofibromatosistype1
AT dabscheckgabriel auditorydysfunctionamongindividualswithneurofibromatosistype1
AT sealmarcl auditorydysfunctionamongindividualswithneurofibromatosistype1
AT delatyckimartinb auditorydysfunctionamongindividualswithneurofibromatosistype1
AT paynejonathanm auditorydysfunctionamongindividualswithneurofibromatosistype1